Press Releases

Samsung Biologics receives the Terra Carta Seal in recognition of the company’s commitment to creating a sustainable future

Isohelix Files US FDA 510k Pre-Submission for GeneFix® Saliva DNA Collectors

Isohelix has announced that it has commenced engagement with the U.S. Food and Drug Administration to progress the full regulatory approval of the GeneFix® Saliva DNA Collectors into the USA.

GenNext Technologies Appoints Dr. Lisa Jones of UCSD to the Role of Chief Science Officer (CSO)

GenNext Technologies has announced the appointment of Dr. Lisa Jones as the company’s new Chief Science Officer.

GenNext Technologies Announces the Appointment of Dr. John Grant from Lemnos Advisory to its Board of Directors

GenNext Technologies, Inc. has announced that Dr. John L. Grant has joined its Board of Directors (BOD).

Argonaut Manufacturing Services Set to Expand Drug Product Fill/Finish Capabilities with Significant Capital Investment

Argonaut Manufacturing Services Set to Expand Drug Product Fill/Finish Capabilities with Significant Capital Investment

Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark

Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark. London, UK and Durham, NC – January 10, 2023 – Phastar announced today the acquisition of S-Cubed ApS, a specialist biometrics and data visualization company. The deal takes the PHASTAR group to around 550 people worldwide and strengthens the company's position in the Nordic region.

SANGUINE BIOSCIENCES PARTNERS WITH BROADOAK CAPITAL PARTNERS TO ACCELERATE LAUNCH OF NEW PRODUCTS AND SERVICES IN SUPPORT OF CELL & GENE THERAPY MARKETS

Investment will support ongoing partnerships with apheresis clinics, expansion of laboratory services, enhancement of patient data aggregation, and amplification of Sanguine’s network of 60,000+ research-ready patient donor network.

Quanticate makes key appointment to bolster leadership team

Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract for National Institute of Neurological Disorders and Stroke

Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract for National Institute of Neurological Disorders and Stroke

Elligo Health Research® Names Dawn Sauro as New Chief Operating Officer

Silver medal from EcoVadis underlines Tower Cold Chain’s sustainability drive

Tower Cold Chain, a leading provider of pharmaceutical temperature-controlled containers, has been awarded the prestigious silver medal from EcoVadis in recognition of the continuing action made by the company towards its sustainability credentials.

Tower’s latest container available for free demonstrations

Tower Cold Chain’s latest product for smaller pharmaceutical shipments, the KTEvolution container offering protection, security, and visibility in a small box, is now available for demonstration globally, at the company’s Centres of Excellence in the EMEA, APAC and Americas regions.

Clinical trial platform provider encapsia welcomes new COO

Clinical trial management solutions provider, encapsia, has announced the appointment of Francis Destin as its new Chief Operating Officer.

Creative Diagnostics Expands Its Monoclonal Antibodies Offering to Customers

Creative Diagnostics expanded its monoclonal antibodies capabilities and offerings to global customers.

CD Bioparticles Introduces Hydrophobic Interaction Chromatography Resins for Purification of Macromolecules

CD Bioparticles launched a range of hydrophobic interaction chromatography resins for the purification of macromolecules including adeno-associated viruses.

STEMart Introduces API Impurity Identification Services for Medical Devices

STEMart has recently introduced API Impurity Identification services for global clients.

Abzena hires Matthew Stober to lead the company through the next phase of global growth

Matthew Stober hired as CEO and joins Abzena Board. Abzena continues growth as the leading provider of development and manufacturing services for Antibody Drug Conjugate (ADC) and complex biologics. Board enhanced with CDMO and Biologics industry luminaries to support future growth.

Curebase Celebrates Year of Growth, Organizational Maturity

Curebase Celebrates Year of Growth, Organizational Maturity

Nearly 480 Cosmetic Ingredients Are Now Available for Research Use

Creative Biogene Has Established More Than 50 Engineered Zebrafish Models to Support Human Cancer Research